• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

ViiV Healthcare gets FDA nod for two-month dosing of Cabenuva to treat HIV

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 02, 2022 at 11:12: AM
via Specialist HIV company ViiV Healthcare has secured the US Food and Drug Administration (FDA) approval for the expanded labelling of Cabenuva (cabotegravir, rilpivirine) to treat HIV-1 in adults.

article source
 

<



Similar threads

cafead
ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato
Replies
0
Views
172
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
ViiV Healthcare gets FDA nod for HIV drug Rukobia to treat adult patients
Replies
0
Views
128
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
ViiV Healthcare Premieres Early Data Showing Antiviral Activity Against Integrase Resistance from its Investigational, Third-Generation Integrase Inhi
Replies
0
Views
28
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
ViiV Healthcare reports data from Phase I trial of HIV drug
Replies
0
Views
82
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
ViiV Healthcare receives European Commission approval for Apretude
Replies
0
Views
59
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote